• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自我血糖监测对土耳其2型糖尿病患者血糖控制的有效性。

Effectiveness for self-monitoring of blood sugar on blood glucose control in Turkish patients with type 2 diabetes mellitus.

作者信息

Baltaci Davut, Kutlucan Ali, Ozturk Serkan, Saritas Ayhan, Celer Ahmet, Celbek Gokham, Deler Harun, Aydin Yusuf, Ankarali Handan

机构信息

Department of Family Medicine, Duzce University, Duzce, Turkey.

出版信息

Med Glas (Zenica). 2012 Aug;9(2):211-7.

PMID:22926352
Abstract

AIM

Diabetes mellitus (DM) is a chronic disease requiring continuous monitoring and treatment. Self-monitoring of blood glucose (SMBG) is frequently recommended. The purpose of the study was to evaluate effectiveness of SMBG on metabolic control in Turkish patients with type 2 DM.

METHODS

The cross-sectional study enrolled type 2 diabetic patients without insulin regimen. The participants were assigned to three groups according to status of SMBG: group 1- regular, group 2 - irregular and group 3 - never SMBG implementation.

RESULTS

A total of 349 patients were enrolled. There was no significant difference in mean fasting and post-prandial blood glucose, lipid profile values between the groups. The number of patients with high education level in group 1 was higher than groups 2 and 3 (p = 0.001). HbA1c level was higher in groups 2 and 3 than group 1, but not significantly (p = 0.285). Mean spot urinary albumin- creatinine ratio (ACR) in group 1 is significantly lower than in groups 2 and 3 (p = 0.008 and p = 0.044, respectively), but no significant difference was observed between group 2 and 3 (p = 0.473).

CONCLUSION

The study indicated that regular use of SMBG was not superior to irregular/never use of SMBG on glycemic control, but it seemed to be good intervention for prevention of diabetic nephropathy. We suggestively offered that SMBG should be recommended for patients with a high education level to meet the goal of its use, and it should be incorporated into self-management with effective educational intervention.

摘要

目的

糖尿病(DM)是一种需要持续监测和治疗的慢性疾病。血糖自我监测(SMBG)经常被推荐。本研究的目的是评估血糖自我监测对土耳其2型糖尿病患者代谢控制的有效性。

方法

这项横断面研究纳入了未使用胰岛素治疗方案的2型糖尿病患者。根据血糖自我监测状况将参与者分为三组:第1组 - 定期监测,第2组 - 不定期监测,第3组 - 从未进行过血糖自我监测。

结果

共纳入349例患者。各组之间的平均空腹和餐后血糖、血脂谱值无显著差异。第1组中高学历患者的数量高于第2组和第3组(p = 0.001)。第2组和第3组的糖化血红蛋白(HbA1c)水平高于第1组,但差异不显著(p = 0.285)。第1组的平均随机尿白蛋白 - 肌酐比值(ACR)显著低于第2组和第3组(分别为p = 0.008和p = 0.044),但第2组和第3组之间未观察到显著差异(p = 0.473)。

结论

该研究表明,在血糖控制方面,定期进行血糖自我监测并不优于不定期/从不进行血糖自我监测,但它似乎是预防糖尿病肾病的良好干预措施。我们建议,对于高学历患者应推荐进行血糖自我监测以实现其使用目的,并且应通过有效的教育干预将其纳入自我管理之中。

相似文献

1
Effectiveness for self-monitoring of blood sugar on blood glucose control in Turkish patients with type 2 diabetes mellitus.自我血糖监测对土耳其2型糖尿病患者血糖控制的有效性。
Med Glas (Zenica). 2012 Aug;9(2):211-7.
2
Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.血糖自我监测频率与长期代谢控制有关吗?对来自德国和奥地利191个中心的24500名患者进行的多中心分析。
Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8. doi: 10.1055/s-2006-924152.
3
Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.血糖自我监测适用于所有2型糖尿病患者吗?弗里曼特尔糖尿病研究。
Diabetes Care. 2006 Aug;29(8):1764-70. doi: 10.2337/dc06-0268.
4
Self-monitoring of blood glucose in type 2 diabetic patients in China: current status and influential factors.中国 2 型糖尿病患者的自我血糖监测:现状及影响因素。
Chin Med J (Engl). 2014;127(2):201-7.
5
[Self-monitoring of blood glucose in type 2 diabetic patients. What could we propose according to their treatment?].[2型糖尿病患者的血糖自我监测。根据其治疗情况我们能提出什么建议?]
Diabetes Metab. 2003 Apr;29(2 Pt 2):S26-30.
6
Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.使用持续葡萄糖监测系统指导胰岛素治疗的糖尿病患者的治疗:一项随机对照试验。
Mayo Clin Proc. 2004 Dec;79(12):1521-6. doi: 10.4065/79.12.1521.
7
Self-monitoring of blood glucose and glycaemic control in type 2 diabetes.2型糖尿病患者的血糖自我监测与血糖控制
Scand J Prim Health Care. 2007 Sep;25(3):140-6. doi: 10.1080/02813430701267413.
8
Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.2001年法国1型和2型糖尿病患者的血糖自我监测:Entred研究
Diabetes Metab. 2008 Jun;34(3):219-26. doi: 10.1016/j.diabet.2007.11.005. Epub 2008 Mar 17.
9
Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?自我血糖监测能否改善2型糖尿病的治疗效果?
Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S112-7. doi: 10.1016/j.diabres.2008.09.025. Epub 2008 Oct 29.
10
Self-monitoring among non-insulin treated patients with type 2 diabetes mellitus: Patients' behavioural responses to readings and associations with glycaemic control.非胰岛素治疗的 2 型糖尿病患者的自我监测:患者对读数的行为反应及其与血糖控制的关系。
Diabetes Res Clin Pract. 2013 May;100(2):235-42. doi: 10.1016/j.diabres.2013.03.005. Epub 2013 Mar 22.

引用本文的文献

1
Glycaemic control and its associated factors in patients with type 2 diabetes in the Middle East and North Africa: An updated systematic review and meta-analysis.中东和北非地区 2 型糖尿病患者的血糖控制及其相关因素:一项更新的系统评价和荟萃分析。
J Adv Nurs. 2022 Aug;78(8):2257-2276. doi: 10.1111/jan.15255. Epub 2022 May 27.
2
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.糖尿病患者的血糖自我监测:从中东欧的证据到临床实践——中东欧国际专家组的建议
Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9.
3
Impact of an education program on patient anxiety, depression, glycemic control, and adherence to self-care and medication in Type 2 diabetes.
一项教育计划对2型糖尿病患者焦虑、抑郁、血糖控制以及自我护理和药物治疗依从性的影响。
J Family Community Med. 2013 May;20(2):77-82. doi: 10.4103/2230-8229.114766.